Merit Medical Systems, Inc. (MMSI)
89.20
-0.37
(-0.41%)
USD |
NASDAQ |
Oct 16, 16:00
89.16
-0.04
(-0.04%)
After-Hours: 20:00
Merit Medical Systems Research and Development Expense (Annual) : 97.35M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 97.35M |
| December 31, 2024 | 87.47M |
| December 31, 2023 | 82.73M |
| December 31, 2022 | 75.51M |
| December 31, 2021 | 71.25M |
| December 31, 2020 | 57.54M |
| December 31, 2019 | 65.62M |
| December 31, 2018 | 59.53M |
| December 31, 2017 | 51.40M |
| December 31, 2016 | 45.23M |
| December 31, 2015 | 40.81M |
| December 31, 2014 | 36.63M |
| December 31, 2013 | 33.89M |
| December 31, 2012 | 27.80M |
| December 31, 2011 | 21.94M |
| December 31, 2010 | 15.34M |
| Date | Value |
|---|---|
| December 31, 2009 | 11.17M |
| December 31, 2008 | 9.16M |
| December 31, 2007 | 8.688M |
| December 31, 2006 | 8.582M |
| December 31, 2005 | 6.992M |
| December 31, 2004 | 5.079M |
| December 31, 2003 | 4.626M |
| December 31, 2002 | 4.008M |
| December 31, 2001 | 4.118M |
| December 31, 2000 | 3.864M |
| December 31, 1999 | 3.618M |
| December 31, 1998 | 3.244M |
| December 31, 1997 | 4.447M |
| December 31, 1996 | 2.533M |
| December 31, 1995 | 2.330M |
| December 31, 1994 | 2.070M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Globus Medical, Inc. | 146.94M |
| Glaukos Corp. | 150.61M |
| Baxter International, Inc. | 503.00M |
| Becton, Dickinson & Co. | 1.265B |
| DexCom, Inc. | 594.90M |